Funding for this research was provided by:
KWF Kankerbestrijding (VU 2011-5279)
Received: 2 October 2018
Accepted: 24 January 2019
First Online: 1 February 2019
Ethics approval and consent to participate
: The study was approved by the Medical Ethics Committee of VU University Medical Center (2013/10). All patients provided written informed consent.
: Not applicable.
: HV receives grants from Roche, Vitromics Healthcare System, Novartis, Immunovo B.V., Amgen, non-financial support from Pfizer, and honoraria from Boehringer Ingelheim. These resources were all received outside the submitted work. The other authors declare no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.